Understanding Fluidized-Bed Granulation - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Understanding Fluidized-Bed Granulation
This study demonstrates the beneficial use of a spatial-filter velocimetry particle-size analyzer during granulation.


Pharmaceutical Technology
Volume 35, Issue 8, pp. 63-67

References

1. S.M. Iveson, et al., Powder Technol. 117 (1–2), 3–39 (2001).

2. T. Naervanen, et al., AAPS PharmSciTech 9 (1), 282–287 (2008).

3. S. Watano, Powder Technol. 117 (1–2), 163–172 (2001).

4. S. Watano and K. Miyanami, Powder Technol. 83 (1), 55–60 (1995).

5. S. Watano et al., Chem. Pharm. Bull. 48 (8), 1154–1159 (2000).

6. S. Watano et al., Powder Technol. 115 (2), 124–130 (2001).

7. S. Watano, Y. Sato, and K. Miyanami, Chem. Pharm. Bull. 44 (8), 1556–1560 (1996).

8. S. Watano, Y. Sato, and K. Miyanami, Adv. Powder. Technol. 8 (4), 269–277 (1997).

9. M. Alcala et al., J. Pharm. Sci. 99 (1), 336–345 (2010).

10. W.P. Findlay, G.R. Peck, and K.R. Morris, J. Pharm. Sci. 94 (3), 604–612 (2005).

11. P. Frake et al., Int. J. Pharm. 151 (1), 75–80 (1997).

12. S.G. Goebel and K.J. Steffens, Pharm. Industrie 60 (10), 889–895 (1998).

13. A.A. Kaddour and B. Cuq, Powder Technol. 190 (1–2), 10–18 (2009).

14. P. Luukkonen et al., J. Pharm. Sci. 97 (2), 950–959 (2008).

15. A. Tok et al., AAPS PharmSciTech 9 (4), 1083–1091 (2008).

16. J.F. Gamble, A.B. Dennis, and M. Tobyn, Pharm. Dev. Technol. 14 (3), 299–304 (2009).

17. M. Halstensen, P. de Bakker, and K.H. Esbensen, Chemom. Intell. Lab. Syst. 84 (1–2), 88–97 (2006).

18. S. Matero et al., Chemom. Intell. Lab. Syst. 97 (1), 75–81 (2009).

19. M. Whitaker et al., Int. J. Pharm. 205 (1–2), 79–91 (2000).

20. X.H. Hu, J.C. Cunningham, and D. Winstead, Int. J. Pharm. 347 (1–2), 54–61 (2008).

21. J. Huang et al., J. Pharm. Sci. 99 (7), 3205–3212 (2010).

22. T. Lipsanen et al., AAPS PharmSciTech. 9 (4), 1070–1077 (2008).

23. T. Narvanen et al., J. Pharm. Sci. 98 (3), 1110–1117 (2009).

24. T. Narvanen et al., Int. J. Pharm. 357 (1–2), 132-138 (2008).

Citation: When referring to this article, please cite it as "A. Burggraeve, T. Van Den Kerkhof, M. Hellings, J.P. Remon, C. Vervaet, T. De Beer, "Understanding Fluidized-Bed Granulation," Pharmaceutical Technology 35 (8) 63-67(2011)."


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here